The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Alcohol Biosensors (STTR)(R41/R42) |
93.273 |
RFA-AA-15-007 |
| Empirical Research on Ethical Issues Related to Central IRBs and Consent for Research Using Clinical Records and Data (R01) |
93.172, 93.173, 93.233, 93.273, 93.307, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-OD-15-002 |
| New Technologies for Viral Hepatitis SBIR (R43/R44) |
93.839, 93.847, 93.865 |
PA-15-077 |
| New Technologies for Viral Hepatitis STTR (R41/R42) |
93.839, 93.847, 93.865 |
PA-15-076 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30) |
93.846 |
RFA-AR-16-003 |
| Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01) |
93.394, 93.395 |
PAR-15-075 |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (U24) |
93.273 |
RFA-AA-15-006 |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (U24) |
93.273 |
RFA-AA-15-005 |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Projects (U01) |
93.273 |
RFA-AA-15-004 |
| Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (U44) |
93.273 |
PAR-15-074 |
| Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2) |
93.273 |
PAR-15-073 |
| Novel Tools to Assess Human Placental Structure and Function (R21) |
93.865 |
RFA-HD-15-031 |
| Novel Tools to Assess Human Placental Structure and Function (R01) |
93.865 |
RFA-HD-15-030 |
| Limited Competition: Addressing Health Disparities in Maternal and Child Health through Community-Based Participatory Research (R03) |
93.865 |
PAR-15-072 |
| Centers for Mendelian Genomics (UM1) |
93.172 |
RFA-HG-15-002 |
| Centers for Common Disease Genomics (UM1) |
93.172 |
RFA-HG-15-001 |
| NIMH Administrative Supplement Program Providing Research Experiences for Physicians and Medical Students from Diverse Backgrounds |
93.242 |
PA-15-069 |
| NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) |
93.853 |
RFA-NS-15-002 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) |
93.853 |
PAR-15-071 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33) |
93.853 |
PAR-15-070 |
| NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34) |
93.847 |
PAR-15-068 |
| NIDDK Multi-Center Clinical Study Cooperative Agreement (U01) |
93.847 |
PAR-15-067 |
| Building on High Impact Basic Neurobiology Through Assay Development: Advancing Tools for Therapeutic Discovery (R01) |
93.242, 93.273, 93.279 |
PAR-15-066 |
| Use of 3-D Printers for the Production of Medical Devices (R41/R42) |
93.865 |
RFA-HD-15-024 |
| Use of 3-D Printers for the Production of Medical Devices (R43/R44) |
93.865 |
RFA-HD-15-023 |
| Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44) |
93.855, 93.856 |
PA-15-065 |
| The NCI Transition Career Development Award (K22) |
93.398 |
PAR-15-056 |
| Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34) |
93.838 |
RFA-HL-15-028 |
| Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U01) |
93.838 |
RFA-HL-17-001 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) |
93.398 |
PAR-15-064 |
| NCI Transition Career Development Award to Promote Diversity (K22) |
93.398 |
PAR-15-063 |
| NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23) |
93.398 |
PAR-15-062 |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) |
93.398 |
PAR-15-060 |
| Research Coordinating Unit for Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations (U24) |
93.837, 93.853 |
RFA-HL-15-031 |
| Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations (UH2/UH3) |
93.837, 93.853 |
RFA-HL-15-021 |
| NIDCR Clinical Trial or Biomarker Clinical Validation Study Cooperative Agreement (U01) |
93.121 |
PAR-15-059 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) |
93.273 |
PA-15-058 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) |
93.273 |
PA-15-057 |
| High Priority Immunology Grants (R01) |
93.855, 93.856 |
PAS-15-055 |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R43/R44) |
93.838 |
RFA-HL-15-027 |
Search Results 7281-7320 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
